厌倦了我
发表于 2025-3-21 16:51:47
书目名称Membrane Defenses Against Attack by Complement and Perforins影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0630358<br><br> <br><br>书目名称Membrane Defenses Against Attack by Complement and Perforins读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0630358<br><br> <br><br>
Hla461
发表于 2025-3-21 23:37:18
http://reply.papertrans.cn/64/6304/630358/630358_2.png
消散
发表于 2025-3-22 04:06:35
http://reply.papertrans.cn/64/6304/630358/630358_3.png
Fabric
发表于 2025-3-22 08:29:17
http://reply.papertrans.cn/64/6304/630358/630358_4.png
jaunty
发表于 2025-3-22 11:47:54
http://reply.papertrans.cn/64/6304/630358/630358_5.png
CRAFT
发表于 2025-3-22 14:42:39
http://reply.papertrans.cn/64/6304/630358/630358_6.png
打算
发表于 2025-3-22 20:10:24
http://reply.papertrans.cn/64/6304/630358/630358_7.png
朝圣者
发表于 2025-3-22 21:11:55
http://reply.papertrans.cn/64/6304/630358/630358_8.png
SCORE
发表于 2025-3-23 03:50:38
0070-217X etween the complement andperforinsystems. The therapeutic use of recombinant CR1for immune-mediated pathophysiological processes isdiscussed in a separate section.978-3-642-77016-6978-3-642-77014-2Series ISSN 0070-217X Series E-ISSN 2196-9965
斜
发表于 2025-3-23 06:24:46
Decay Accelerating Factor (CD55), phase and within the membranes of host cells. The structure, function, and expression of one important membrane regulator of complement, namely, the decay accelerating factor (DAF), will be reviewed here.